Cognito Therapeutics

Cambridge, MA · Founded 2016 · Privately Held (backing)

Developer of digital therapeutics designed to treat neurodegenerative disorders by modulating brain activity and targeting underlying disease mechanisms associated with cognitive decline. Cognito Therapeutics is based in Cambridge, MA and was founded in 2016. Its last reported valuation was $30 million in Jul 2016. It has raised $264 million across 2 recorded rounds; the latest was a $10.2 million early-stage round in Jun 2024.

Last reported valuation
$30.0M
Oct 2026
Priced at
—
Total raised
$264.4M
Last round
Early Stage VC
Jun 2024
What is Cognito Therapeutics worth?
$30.0Mlast reported valuation · Oct 2026

Cognito Therapeutics's last reported valuation, Jul 2016. Nothing priced has surfaced since.

Free account
More of Cognito Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Cognito Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Cognito Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Jun 2024Early Stage VC$10.2M▮
Jun 2022Later Stage VC$108.8M▮
Unlock post-money valuations

Membership and data by Private Market View

Cognito Therapeutics valuation

Cognito Therapeutics's last reported valuation was $30 million in Jul 2016. No priced round, secondary trade or fund mark has surfaced since.

How much has Cognito Therapeutics raised?

Cognito Therapeutics has raised $264 million in total; 2 of its rounds are on record. The largest on record was a $109 million later-stage round in Jun 2022; the most recent was a $10.2 million early-stage round in Jun 2024.

Cognito Therapeutics has filed 3 Form Ds with the SEC since 2022, most recently in Jul 2024 ($10.2 million sold to 3 investors).

How Cognito Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cognito Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Cognito Therapeutics

What is Cognito Therapeutics worth?
Cognito Therapeutics is valued at $30.0M as of Oct 2026. Cognito Therapeutics's last reported valuation, Jul 2016. Nothing priced has surfaced since.
How much has Cognito Therapeutics raised?
Cognito Therapeutics has raised $264.4M in total funding across 2 recorded rounds.
When did Cognito Therapeutics last raise?
Cognito Therapeutics last raised in Jun 2024 (Early Stage VC), raising $10.2M.